🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if oral decitabine-cedazuridine (I...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT06351306
Treatments Being Tested
The goal of this clinical research study is to compare how 2 different drug...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2014-10-13
Trial ID
NCT02269280
This is a prospective,controlled and multi-institution trial.The aim is to ...
Status
Withdrawn
Location
Ruijin Hospital North
Start Date
2018-03-20
Trial ID
NCT03377725
Treatments Being Tested
STUDY BACKGROUND AND PURPOSE: Acute myelogenous leukemia (AML) is a common...
Status
Terminated
Location
Winship Cancer Institute of Emory University
Start Date
2013-11
Trial ID
NCT02234037
Treatments Being Tested
This study aims to determine whether the recurrence rate of high-risk acute...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-01-01
Trial ID
NCT07101588
Treatments Being Tested
The primary objective of study Part A is to assess the safety of talacotuzu...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-04
Trial ID
NCT02472145
Treatments Being Tested
The investigators reported previously that epigenetic activation of organic...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2019-08-15
Trial ID
NCT04049344
Treatments Being Tested
The purpose of this research study is to see if people whose Acute myeloid ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-11-07
Trial ID
NCT06511882
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
To evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-06-12
Trial ID
NCT04155580